<?xml version="1.0" encoding="UTF-8"?>
<p>Melatonin is another drug that has been proposed as a potential anti-inflammatory drug to relieve the symptoms of SARS-CoV-2 infection. Viral infections cause injury of the immune system that is commonly associated with oxidative stress and damage of organs [
 <xref rid="B133" ref-type="bibr">133</xref>]. Melatonin is an old biogenic amine for treating sleep disturbances and circadian rhythm. It has an antioxidant effect and has been previously encouraged to be used for Ebola viral infection [
 <xref rid="B134" ref-type="bibr">134</xref>]. As suggested by ChengÂ 
 <italic>et al.</italic>, melatonin could reduce the clinical symptoms of SARS-CoV-2 infection and prolong the survival time for the patient.
</p>
